Short-term Clinical Effects of Intravitreal Aflibercept Injection 2.0mg as a Predictor of Long-term Results

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Valley Retina Institute
Information provided by (Responsible Party):
Rhonda Weeks, Retina Research Institute, LLC
ClinicalTrials.gov Identifier:
NCT01657669
First received: August 2, 2012
Last updated: July 24, 2015
Last verified: July 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2015
  Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)